Lithoz says that its materials revenue has risen 40% year on year. This is a good sign pointing towards higher utilization and production volumes by its customers. Service bureaus and medical firms boosted Q2 revenue growth. The company also says that 20% of its customers run 50% of all the CeraFab systems worldwide. On the one hand, this is a supplier concentration, but on the other hand, it also points to efficient production partners who are growing into specialized 3D printing ceramics manufacturing firms. The three most significant growth areas for the firm are in aluminum nitride, silica-based ceramics, and calcium phosphates. With calcium phosphates used in medical applications, silica in casting, and nitride in electronics applications, this shows a clear split between three very different industries. This multi-industry growth will be a significant advantage to the firm going forward. It also contrasts with the usual dependence the market has on mainstays alumina and zirconia.
Traditionally, many LPBF-based firms were highly reliant on titanium, specifically orthopedic implants. It’s a great industry, a good application, and it has good economics. But a shift away from 3D printing would have a hugely detrimental impact on laser powder bed fusion (LPBF). Lithoz, meanwhile, can grow in things like bone replacement and patient-specific resorbable implants more generally while also gaining exposure to consumer electronics, semiconductors, and aerospace through heat management for electronics. That industry in and of itself is potentially huge, but the firm could also grow in casting cores. This is a nice position to be in, especially as the entire rest of the industry piles into defense. That focus and concentration could be very detrimental as well should defense departments somehow sour on 3D printing. The company also points to continued expansion of its installed base, with existing customers adding more LCM printers to production fleets.
Lithoz CEO Johannes Homa stated that,
“We are not only continuously improving and revalidating our materials. We’ve even developed a good number of customized materials for customers now persistently scaling their production to greater volumes. Reaching ISO 13485 certification for our quality management in material production was a big milestone and proved to be a powerful door opener to many demanding industries; even the most tightly regulated industries that can profit off our technology.”
Lithoz Casting Core Range on build platform. Image courtesy of Lithoz.
The company hopes that future significant growth will come from resorbable implants. This area has huge potential, allowing for implants to not remain inside the body but essentially disappear when no longer needed. Some of these implants are also patient-specific, which could be a high-value growth area. The adoption of resorbable ceramic implants will take time. It took 3D printed titanium 30 years to become commonplace in sp
Lithoz says that its materials revenue has risen 40% year on year. This is a good sign pointing towards higher utilization and production volumes by its customers. Service bureaus and medical firms boosted Q2 revenue growth. The company also says that 20% of its customers run 50% of all the CeraFab systems worldwide. On the one hand, this is a supplier concentration, but on the other hand, it also points to efficient production partners who are growing into specialized 3D printing ceramics manufacturing firms. The three most significant growth areas for the firm are in aluminum nitride, silica-based ceramics, and calcium phosphates. With calcium phosphates used in medical applications, silica in casting, and nitride in electronics applications, this shows a clear split between three very different industries. This multi-industry growth will be a significant advantage to the firm going forward. It also contrasts with the usual dependence the market has on mainstays alumina and zirconia.
Traditionally, many LPBF-based firms were highly reliant on titanium, specifically orthopedic implants. It’s a great industry, a good application, and it has good economics. But a shift away from 3D printing would have a hugely detrimental impact on laser powder bed fusion (LPBF). Lithoz, meanwhile, can grow in things like bone replacement and patient-specific resorbable implants more generally while also gaining exposure to consumer electronics, semiconductors, and aerospace through heat management for electronics. That industry in and of itself is potentially huge, but the firm could also grow in casting cores. This is a nice position to be in, especially as the entire rest of the industry piles into defense. That focus and concentration could be very detrimental as well should defense departments somehow sour on 3D printing. The company also points to continued expansion of its installed base, with existing customers adding more LCM printers to production fleets.
Lithoz CEO Johannes Homa stated that,
“We are not only continuously improving and revalidating our materials. We’ve even developed a good number of customized materials for customers now persistently scaling their production to greater volumes. Reaching ISO 13485 certification for our quality management in material production was a big milestone and proved to be a powerful door opener to many demanding industries; even the most tightly regulated industries that can profit off our technology.”
Lithoz Casting Core Range on build platform. Image courtesy of Lithoz.
The company hopes that future significant growth will come from resorbable implants. This area has huge potential, allowing for implants to not remain inside the body but essentially disappear when no longer needed. Some of these implants are also patient-specific, which could be a high-value growth area. The adoption of resorbable ceramic implants will take time. It took 3D printed titanium 30 years to become commonplace in sp